Immix Biopharma (IMMX) Current Leases (2024 - 2026)

Immix Biopharma has reported Current Leases for 3 years, with the latest figure at $125392.0 in Q1 2026.

• Quarterly Current Leases rose 84.9% year-over-year to $125392.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125392.0 (up 84.9% YoY) and the FY2025 annual result came in at $139339.0, up 113.65% from the prior year.
• Current Leases eased to $125392.0 in Q1 2026 per IMMX's latest filing, from $139339.0 in the prior quarter.
• Over five years, Current Leases peaked at $141282.0 in Q3 2025 and troughed at $34284.0 in Q1 2024.
• A 3-year average of $83874.9 and a median of $67817.0 in 2025 frame the typical range for Current Leases.
• The widest YoY moves for Current Leases: up 125.28% in 2025, down 45.72% in 2025.
• Over 3 years, Current Leases stood at $65219.0 in 2024, then surged by 113.65% to $139339.0 in 2025, then fell by 10.01% to $125392.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $125392.0, $139339.0, and $141282.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.